Dr. Kazu Okuda, Founder, and CEO of Universal Brain, uses neurotyping based on EEG data to better understand the different types of depression and deliver more precise treatments. To facilitate the availability of EEG data, Universal Brain has developed a next-generation EEG headset that is affordable and comfortable. The headset allows for the collection of data that can be used to analyze neural profiles of patients and tailor treatments. This precision psychiatry approach is the future of depression treatment and for identifying early warning signs of depression in the younger population. K ..read more

Dr. Kazu Okuda, Founder, and CEO of Universal Brain, uses neurotyping based on EEG data to better understand the different types of depression and deliver more precise treatments. To facilitate the availability of EEG data, Universal Brain has developed a next-generation EEG headset that is affordable and comfortable. The headset allows for the collection of data that can be used to analyze neural profiles of patients and tailor treatments. This precision psychiatry approach is the future of depression treatment and for identifying early warning signs of depression in the younger population. K ..read more

Greg Sturmer, CEO and Co-Founder, and Tom Jenkins, Chief Science Officer and Co-Founder of Elysium Therapeutics, talk about their SMART Opioid O2P, which aims to address the risks of taking opioids while still delivering the analgesic efficacy of opioids.  The compound is designed to be resistant to abuse through snorting or injections and includes a trypsin inhibitor that prevents the release of the opioid when multiple pills are ingested. Elysium is also developing SOOPR, an opioid overdose rescue medication that has a longer duration of action to counteract the longer-lasting effects o ..read more

Greg Sturmer, CEO and Co-Founder, and Tom Jenkins, Chief Science Officer and Co-Founder of Elysium Therapeutics, talk about their SMART Opioid O2P, which aims to address the risks of taking opioids while still delivering the analgesic efficacy of opioids.  The compound is designed to be resistant to abuse through snorting or injections and includes a trypsin inhibitor that prevents the release of the opioid when multiple pills are ingested. Elysium is also developing SOOPR, an opioid overdose rescue medication that has a longer duration of action to counteract the longer-lasting effects o ..read more

Dr. Nate Favini, the first Chief Medical Officer of Pair Team, aims to connect underserved communities to high-quality, ongoing healthcare by providing medical, behavioral, and social services. Working with people who rely on Medicaid, who are experiencing homelessness and substance use disorders, and who have had recent interactions with the criminal justice system requires innovation and collaboration of government agencies, community-based organizations, and healthcare providers. With a focus on outcomes and cost, this value-based approach is reaching patients where they are, often using mo ..read more

Dr. Nate Favini, the first Chief Medical Officer of Pair Team, aims to connect underserved communities to high-quality, ongoing healthcare by providing medical, behavioral, and social services. Working with people who rely on Medicaid, who are experiencing homelessness and substance use disorders, and who have had recent interactions with the criminal justice system requires innovation and collaboration of government agencies, community-based organizations, and healthcare providers. With a focus on outcomes and cost, this value-based approach is reaching patients where they are, often using mo ..read more

Daniel Barvin, VP of Operations and Patient Advocacy at Coya Therapeutics discusses the challenges of treating ALS (Amyotrophic Lateral Sclerosis) and the company's approach to developing therapies for this heterogeneous disease.  Focusing on a combination modality, Coya is developing therapies effective for sporadic and genetic ALS, targeting regulatory T cells and reducing inflammation to slow disease progression. Daniel, who carries a genetic variant for ALS and FTD (Frontotemporal Dementia), emphasizes the need for resources and support for the next generation of pre-symptomatic genet ..read more

Dr. Bala Hota, Senior VP and Chief Informatics Officer at Tendo, emphasizes the importance of leveraging data to improve patient care and operational performance in healthcare and overcome biases in access. Focusing on quality measures and integration of structured and unstructured data, Tendo has developed services that support providers, patients, and caregivers using multiple avenues of communication.  The acquisition of MDsave allows for a marketplace that provides transparent pricing for medical services, adding to this omnichannel healthcare model. Bala explains, "At Tendo, our visi ..read more

Dr. Bala Hota, Senior VP and Chief Informatics Officer at Tendo, emphasizes the importance of leveraging data to improve patient care and operational performance in healthcare and overcome biases in access. Focusing on quality measures and integration of structured and unstructured data, Tendo has developed services that support providers, patients, and caregivers using multiple avenues of communication.  The acquisition of MDsave allows for a marketplace that provides transparent pricing for medical services, adding to this omnichannel healthcare model. Bala explains, "At Tendo, our visi ..read more

Dr. Philip Chenette, a fertility doctor with over 20 years of experience, talks with Deepak Puri, CEO of Democracy Labs, about misunderstandings about reproductive health and the political ramifications. They discuss the role of doctors in educating patients and politicians about fertility treatments and the importance of the patient's voice and vote to protect reproductive rights.   Deepak sets the stage, "Patients often don't connect the dots. So, having a doctor explain, these are the complications, this is what's happening, this is why I cannot treat IVF for you because regulations an ..read more